Theravance Biopharma Inc (TBPH) — Long-term Investment Intensity
Theravance Biopharma Inc (TBPH) has a Long-term Investment Intensity of 2.3% as of December 2025. Long-term investments of $11.13 Million represent 2.3% of total assets of $485.57 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check how resilient are Theravance Biopharma Inc's assets to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Theravance Biopharma Inc Long-term Investment Intensity (2013–2025)
This chart shows how Theravance Biopharma Inc's Long-term Investment Intensity has evolved across 10 annual periods from 2013 to 2025. As of December 2025, the intensity stands at 2.3%, reflecting long-term investments of $11.13 Million against total assets of $485.57 Million USD. For the complete balance sheet picture, see TBPH total assets.
Annual Long-term Investment Intensity for Theravance Biopharma Inc (2013–2025)
The table below presents the year-by-year Long-term Investment Intensity for Theravance Biopharma Inc from 2013 to 2025, covering 10 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read TBPH total debt and obligations for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 2.3% | $11.13 Million | $485.57 Million | ▼ -15.7 pp |
| 2021 | 18.0% | $67.54 Million | $374.82 Million | ▲ +15.3 pp |
| 2020 | 2.7% | $12.75 Million | $469.06 Million | ▲ +0.6 pp |
| 2019 | 2.1% | $8.67 Million | $408.83 Million | ▲ +0.0 pp |
| 2018 | 2.1% | $11.87 Million | $560.24 Million | ▼ -9.2 pp |
| 2017 | 11.3% | $49.78 Million | $441.40 Million | ▼ -4.3 pp |
| 2016 | 15.6% | $99.56 Million | $639.25 Million | ▼ -1.4 pp |
| 2015 | 16.9% | $50.86 Million | $300.12 Million | ▲ +1.7 pp |
| 2014 | 15.2% | $51.40 Million | $337.77 Million | ▼ -187.3 pp |
| 2013 | 202.6% | $51.00 Million | $25.18 Million | — |